Latest news with #WanguoGoldGroup
Yahoo
01-08-2025
- Business
- Yahoo
3 Asian Stocks Estimated To Be Up To 40.9% Below Intrinsic Value
As trade negotiations between major economies progress, Asian markets have shown resilience, with Chinese and Japanese indices posting gains amid optimism over tariff discussions. In this environment, identifying undervalued stocks can be a strategic move for investors seeking opportunities to capitalize on potential market corrections or growth in these regions. Top 10 Undervalued Stocks Based On Cash Flows In Asia Name Current Price Fair Value (Est) Discount (Est) Wanguo Gold Group (SEHK:3939) HK$30.40 HK$60.10 49.4% Suzhou Zelgen BiopharmaceuticalsLtd (SHSE:688266) CN¥111.83 CN¥222.46 49.7% SpiderPlus (TSE:4192) ¥500.00 ¥991.05 49.5% Shenzhen KSTAR Science and Technology (SZSE:002518) CN¥23.17 CN¥46.13 49.8% Sheng Siong Group (SGX:OV8) SGD2.10 SGD4.16 49.5% Nan Ya Printed Circuit Board (TWSE:8046) NT$177.50 NT$349.25 49.2% Insource (TSE:6200) ¥923.00 ¥1827.05 49.5% Forum Engineering (TSE:7088) ¥1222.00 ¥2414.31 49.4% Elan (TSE:6099) ¥858.00 ¥1694.90 49.4% ALUX (KOSDAQ:A475580) ₩11360.00 ₩22580.69 49.7% Click here to see the full list of 268 stocks from our Undervalued Asian Stocks Based On Cash Flows screener. Let's dive into some prime choices out of the screener. Innovent Biologics Overview: Innovent Biologics, Inc. is a biopharmaceutical company focused on the research and development of antibody and protein medicine products across China, the United States, and internationally, with a market cap of approximately HK$167.52 billion. Operations: The company's revenue primarily comes from its biotechnology segment, generating approximately CN¥9.42 billion. Estimated Discount To Fair Value: 17% Innovent Biologics appears undervalued based on discounted cash flow analysis, trading at HK$98 against a fair value estimate of HK$118.1. Despite low forecasted return on equity, the company's earnings growth is expected to outpace the market significantly, driven by innovative therapies like IBI343 for gastric cancer and mazdutide for obesity management. Recent clinical milestones and a successful follow-on equity offering of HK$4.31 billion bolster its financial position and growth potential in Asia's biopharmaceutical landscape. Our comprehensive growth report raises the possibility that Innovent Biologics is poised for substantial financial growth. Get an in-depth perspective on Innovent Biologics' balance sheet by reading our health report here. Shanghai Conant Optical Overview: Shanghai Conant Optical Co., Ltd. manufactures and sells resin spectacle lenses across Mainland China, the Americas, Asia, Europe, Oceania, and Africa with a market cap of HK$21.02 billion. Operations: The company's revenue primarily comes from the manufacturing and sales of resin spectacle lenses, amounting to CN¥2.06 billion. Estimated Discount To Fair Value: 40.9% Shanghai Conant Optical is trading at HK$43.8, significantly below its fair value estimate of HK$74.1, suggesting undervaluation based on discounted cash flow analysis. The company's earnings are forecast to grow faster than the Hong Kong market at 19% annually, supported by strong sales in high refractive index products. Recent guidance indicates a net profit increase of at least 30% for the first half of 2025, driven by increased average selling prices and product mix improvements. According our earnings growth report, there's an indication that Shanghai Conant Optical might be ready to expand. Take a closer look at Shanghai Conant Optical's balance sheet health here in our report. Sichuan Kelun-Biotech Biopharmaceutical Overview: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. is a biopharmaceutical company focused on the research, development, manufacturing, and commercialization of novel drugs in oncology and immunology both in China and internationally, with a market capitalization of approximately HK$95.07 billion. Operations: The company generates revenue primarily from its pharmaceuticals segment, amounting to approximately CN¥1.93 billion. Estimated Discount To Fair Value: 24.7% Sichuan Kelun-Biotech Biopharmaceutical is trading at HK$416, below its estimated fair value of HK$552.16, reflecting potential undervaluation based on cash flows. Revenue growth is projected at 28.4% annually, surpassing the Hong Kong market's average and highlighting robust expansion prospects. The company anticipates becoming profitable within three years, with earnings expected to grow by 37% per year. Recent developments include a follow-on equity offering of HK$1.96 billion and significant progress in clinical trials for innovative cancer treatments. Our expertly prepared growth report on Sichuan Kelun-Biotech Biopharmaceutical implies its future financial outlook may be stronger than recent results. Click to explore a detailed breakdown of our findings in Sichuan Kelun-Biotech Biopharmaceutical's balance sheet health report. Turning Ideas Into Actions Get an in-depth perspective on all 268 Undervalued Asian Stocks Based On Cash Flows by using our screener here. Are any of these part of your asset mix? Tap into the analytical power of Simply Wall St's portfolio to get a 360-degree view on how they're shaping up. Simply Wall St is your key to unlocking global market trends, a free user-friendly app for forward-thinking investors. Seeking Other Investments? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include SEHK:1801 SEHK:2276 and SEHK:6990. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Yahoo
01-08-2025
- Business
- Yahoo
3 Asian Stocks Estimated To Be Up To 29.6% Below Intrinsic Value
As global markets experience shifts driven by new trade deals and economic data, Asia's stock markets are responding with notable movements, particularly in China and Japan. In this environment of evolving trade relations and economic indicators, identifying stocks that may be undervalued can provide investors with potential opportunities to explore intrinsic value discrepancies. Top 10 Undervalued Stocks Based On Cash Flows In Asia Name Current Price Fair Value (Est) Discount (Est) Wanguo Gold Group (SEHK:3939) HK$30.40 HK$60.10 49.4% Suzhou Zelgen BiopharmaceuticalsLtd (SHSE:688266) CN¥111.83 CN¥222.46 49.7% SpiderPlus (TSE:4192) ¥500.00 ¥991.05 49.5% Shenzhen KSTAR Science and Technology (SZSE:002518) CN¥23.17 CN¥46.13 49.8% Sheng Siong Group (SGX:OV8) SGD2.10 SGD4.16 49.5% Nan Ya Printed Circuit Board (TWSE:8046) NT$177.50 NT$349.25 49.2% Insource (TSE:6200) ¥923.00 ¥1827.05 49.5% Forum Engineering (TSE:7088) ¥1222.00 ¥2414.31 49.4% Elan (TSE:6099) ¥858.00 ¥1694.90 49.4% ALUX (KOSDAQ:A475580) ₩11360.00 ₩22580.69 49.7% Click here to see the full list of 268 stocks from our Undervalued Asian Stocks Based On Cash Flows screener. Below we spotlight a couple of our favorites from our exclusive screener. HANMI Semiconductor Overview: HANMI Semiconductor Co., Ltd. manufactures and sells semiconductor equipment both in South Korea and internationally, with a market cap of ₩8.60 trillion. Operations: HANMI Semiconductor Co., Ltd. generates its revenue primarily from the semiconductor segment, amounting to ₩628.99 billion. Estimated Discount To Fair Value: 24% HANMI Semiconductor is trading at ₩91,900, significantly below its estimated fair value of ₩120,965.96, indicating potential undervaluation based on cash flows. Earnings are forecasted to grow 43.5% annually over the next three years, outpacing the Korean market's growth rate. Despite a drop in profit margins from last year and large one-off items affecting results, revenue growth is expected to remain robust at 20.5% per year. Recent updates highlight advancements in AI semiconductor technology and bonding solutions. In light of our recent growth report, it seems possible that HANMI Semiconductor's financial performance will exceed current levels. Delve into the full analysis health report here for a deeper understanding of HANMI Semiconductor. Kuaishou Technology Overview: Kuaishou Technology is an investment holding company that offers live streaming, online marketing, and other services in the People's Republic of China, with a market cap of HK$331.64 billion. Operations: The company's revenue segments include Domestic operations generating CN¥125.08 billion and Overseas operations contributing CN¥5.02 billion. Estimated Discount To Fair Value: 29.6% Kuaishou Technology is trading at HK$77, well below its estimated fair value of HK$109.39, presenting potential undervaluation based on cash flows. Earnings are projected to grow 16.46% annually, surpassing the Hong Kong market's growth rate of 10.6%. Recent buybacks totaling HK$5.15 billion reflect confidence in future prospects despite a slight decline in net income for Q1 2025 compared to the previous year, while sales increased from CNY 29,408 million to CNY 32,608 million. The growth report we've compiled suggests that Kuaishou Technology's future prospects could be on the up. Click here to discover the nuances of Kuaishou Technology with our detailed financial health report. Nippon Electric Glass Overview: Nippon Electric Glass Co., Ltd. manufactures and sells specialty glass products and glass making machinery both in Japan and internationally, with a market capitalization of ¥312.72 billion. Operations: The company's revenue segments include specialty glass products and glass making machinery, serving both domestic and international markets. Estimated Discount To Fair Value: 27.9% Nippon Electric Glass is trading at ¥4,055, significantly below its estimated fair value of ¥5,627.69, indicating undervaluation based on cash flows. The company recently completed a share buyback and cancelled treasury shares to enhance shareholder value. Despite a low forecasted return on equity of 5.7%, earnings are expected to grow 39.09% annually over the next three years, outpacing market growth rates and suggesting potential for improved profitability amid strategic business restructuring efforts. Upon reviewing our latest growth report, Nippon Electric Glass' projected financial performance appears quite optimistic. Click here and access our complete balance sheet health report to understand the dynamics of Nippon Electric Glass. Make It Happen Click this link to deep-dive into the 268 companies within our Undervalued Asian Stocks Based On Cash Flows screener. Have a stake in these businesses? Integrate your holdings into Simply Wall St's portfolio for notifications and detailed stock reports. Join a community of smart investors by using Simply Wall St. It's free and delivers expert-level analysis on worldwide markets. Ready To Venture Into Other Investment Styles? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include KOSE:A042700 SEHK:1024 and TSE:5214. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
Yahoo
17-07-2025
- Business
- Yahoo
3 Asian Stocks Estimated To Be Up To 48.5% Below Intrinsic Value
As global markets navigate the complexities of new U.S. tariffs and mixed economic signals, Asian markets have shown resilience, with China's stimulus hopes buoying investor sentiment. In this environment, identifying undervalued stocks becomes crucial for investors seeking opportunities amidst uncertainty, as these stocks may offer potential value when their intrinsic worth is not fully recognized by the market. Top 10 Undervalued Stocks Based On Cash Flows In Asia Name Current Price Fair Value (Est) Discount (Est) Taiyo Yuden (TSE:6976) ¥2553.00 ¥5091.29 49.9% SILICON2 (KOSDAQ:A257720) ₩52900.00 ₩104284.28 49.3% Range Intelligent Computing Technology Group (SZSE:300442) CN¥52.83 CN¥104.19 49.3% Medy-Tox (KOSDAQ:A086900) ₩162400.00 ₩322233.66 49.6% Mandom (TSE:4917) ¥1442.00 ¥2835.83 49.2% Lucky Harvest (SZSE:002965) CN¥35.03 CN¥69.40 49.5% Hugel (KOSDAQ:A145020) ₩355000.00 ₩698441.84 49.2% HL Holdings (KOSE:A060980) ₩41650.00 ₩82439.98 49.5% Heartland Group Holdings (NZSE:HGH) NZ$0.82 NZ$1.62 49.5% ALUX (KOSDAQ:A475580) ₩11490.00 ₩22641.19 49.3% Click here to see the full list of 262 stocks from our Undervalued Asian Stocks Based On Cash Flows screener. Underneath we present a selection of stocks filtered out by our screen. Wanguo Gold Group Overview: Wanguo Gold Group Limited is an investment holding company involved in mining, ore processing, and the sale of concentrate products in the People's Republic of China and Solomon Islands, with a market cap of HK$33.38 billion. Operations: The company's revenue is derived from the Yifeng Project, contributing CN¥687.63 million, and the Solomon Project, which accounts for CN¥1.19 billion. Estimated Discount To Fair Value: 48.5% Wanguo Gold Group is trading at HK$30.8, significantly below its estimated fair value of HK$59.82, indicating potential undervaluation based on cash flows. Despite a volatile share price and past shareholder dilution, the company's earnings are forecast to grow significantly at 33.8% annually, outpacing the Hong Kong market's growth rate. Recent board changes and dividend declarations highlight active corporate governance and shareholder returns, with a special dividend of 7.5 RMB cents per share announced in June 2025. Insights from our recent growth report point to a promising forecast for Wanguo Gold Group's business outlook. Click to explore a detailed breakdown of our findings in Wanguo Gold Group's balance sheet health report. Singapore Technologies Engineering Overview: Singapore Technologies Engineering Ltd is a global technology, defence, and engineering company with a market cap of SGD26.04 billion. Operations: The company generates revenue from three primary segments: Commercial Aerospace (SGD4.44 billion), Urban Solutions & Satcom (SGD2.01 billion), and Defence & Public Security (SGD4.97 billion). Estimated Discount To Fair Value: 13.8% Singapore Technologies Engineering is trading at S$8.34, below its estimated fair value of S$9.68, suggesting potential undervaluation based on cash flows. Revenue and earnings are projected to grow faster than the Singapore market, despite a high debt level. Recent contract wins totaling $4.4 billion across various segments bolster future growth prospects but may not materially impact current financial metrics immediately due to their long-term nature and execution timelines. Our growth report here indicates Singapore Technologies Engineering may be poised for an improving outlook. Dive into the specifics of Singapore Technologies Engineering here with our thorough financial health report. King Yuan Electronics Overview: King Yuan Electronics Co., Ltd. provides design, manufacturing, selling, testing, and assembly services for integrated circuits across Taiwan, Asia, North America, and internationally with a market cap of NT$133.89 billion. Operations: The company's revenue from Contract Electronics Manufacturing Services is NT$28.19 billion. Estimated Discount To Fair Value: 20.1% King Yuan Electronics, trading at NT$109.5, is valued below its estimated fair value of NT$137.05, highlighting potential undervaluation based on cash flows. Earnings are forecast to grow significantly at 25% annually over the next three years, outpacing Taiwan's market growth rate. Recent earnings results show substantial improvement with net income rising to TWD 4.29 billion from TWD 1.37 billion year-on-year, supporting robust cash flow generation despite a dividend not fully covered by earnings or free cash flows. The growth report we've compiled suggests that King Yuan Electronics' future prospects could be on the up. Get an in-depth perspective on King Yuan Electronics' balance sheet by reading our health report here. Seize The Opportunity Explore the 262 names from our Undervalued Asian Stocks Based On Cash Flows screener here. Got skin in the game with these stocks? Elevate how you manage them by using Simply Wall St's portfolio, where intuitive tools await to help optimize your investment outcomes. Join a community of smart investors by using Simply Wall St. It's free and delivers expert-level analysis on worldwide markets. Ready For A Different Approach? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include SEHK:3939 SGX:S63 and TWSE:2449. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
10-07-2025
- Business
- Yahoo
Asian Market Value Stocks: Zhejiang China Commodities City Group Among 3 Estimated Below Intrinsic Value
As global markets experience fluctuations, with mixed performances across major indices and economic data presenting a varied outlook, investors are increasingly turning their attention to the Asian markets for potential opportunities. In this context, identifying stocks that may be undervalued relative to their intrinsic value can offer strategic advantages, especially in economies like China where recent indicators suggest both challenges and opportunities. Name Current Price Fair Value (Est) Discount (Est) Wanguo Gold Group (SEHK:3939) HK$30.25 HK$59.90 49.5% JRCLtd (TSE:6224) ¥1160.00 ¥2305.91 49.7% Jiangxi Rimag Group (SEHK:2522) HK$13.62 HK$27.23 50% Hibino (TSE:2469) ¥2365.00 ¥4709.96 49.8% Heartland Group Holdings (NZSE:HGH) NZ$0.82 NZ$1.63 49.5% Guangdong Marubi Biotechnology (SHSE:603983) CN¥42.35 CN¥84.40 49.8% Dive (TSE:151A) ¥935.00 ¥1857.63 49.7% Darbond Technology (SHSE:688035) CN¥39.53 CN¥78.42 49.6% cottaLTD (TSE:3359) ¥430.00 ¥855.22 49.7% Beijing Kawin Technology Share-Holding (SHSE:688687) CN¥26.51 CN¥52.74 49.7% Click here to see the full list of 277 stocks from our Undervalued Asian Stocks Based On Cash Flows screener. We'll examine a selection from our screener results. Overview: Zhejiang China Commodities City Group Co., Ltd. develops, manages, and operates a service online trading platform in China with a market cap of CN¥105.62 billion. Operations: Zhejiang China Commodities City Group Co., Ltd.'s revenue segments include the development, management, and operation of an online trading service platform in China. Estimated Discount To Fair Value: 23.2% Zhejiang China Commodities City Group is trading at CN¥19.26, significantly below its fair value estimate of CN¥25.08, highlighting its undervaluation based on cash flows. With forecasted revenue growth of 22.7% annually and earnings expected to grow by 26.67% per year, the company shows strong potential despite an unstable dividend history. Recent removal from the Shanghai Stock Exchange 180 Value Index may impact investor perception but not fundamental cash flow valuation metrics. According our earnings growth report, there's an indication that Zhejiang China Commodities City Group might be ready to expand. Get an in-depth perspective on Zhejiang China Commodities City Group's balance sheet by reading our health report here. Overview: Taiwan Union Technology Corporation manufactures and sells copper foil substrates, adhesive sheets, and multi-layer laminated boards both in Taiwan and internationally, with a market cap of NT$69.06 billion. Operations: Taiwan Union Technology's revenue is primarily derived from the production and sale of copper foil substrates, adhesive sheets, and multi-layer laminated boards. Estimated Discount To Fair Value: 45.3% Taiwan Union Technology is trading at NT$250, significantly below its estimated fair value of NT$457.14, indicating undervaluation based on cash flows. Despite a dividend yield of 2.6% not being well covered by free cash flows, earnings and revenue are forecast to grow faster than the Taiwan market at 21.7% and 15.5% per year respectively. Recent earnings reports show strong growth with net income increasing to TWD 671.95 million from TWD 451.84 million year-over-year. Our expertly prepared growth report on Taiwan Union Technology implies its future financial outlook may be stronger than recent results. Delve into the full analysis health report here for a deeper understanding of Taiwan Union Technology. Overview: OMRON Corporation operates globally in industrial automation, device and module solutions, social systems, and healthcare sectors with a market cap of ¥795.45 billion. Operations: The company's revenue segments include industrial automation, device and module solutions, social systems, and healthcare businesses. Estimated Discount To Fair Value: 36.2% OMRON is trading at ¥4040, significantly below its estimated fair value of ¥6329.02, highlighting its undervaluation based on cash flows. Earnings are expected to grow at 25.3% annually, surpassing the Japanese market's growth rate of 7.5%. However, the dividend yield of 2.57% is not well covered by earnings or free cash flows. Recent strategic partnership with Japan Activation Capital could impact future financials positively but also adds uncertainty regarding minority stake acquisition outcomes. The analysis detailed in our OMRON growth report hints at robust future financial performance. Click to explore a detailed breakdown of our findings in OMRON's balance sheet health report. Investigate our full lineup of 277 Undervalued Asian Stocks Based On Cash Flows right here. Are you invested in these stocks already? Keep abreast of every twist and turn by setting up a portfolio with Simply Wall St, where we make it simple for investors like you to stay informed and proactive. Maximize your investment potential with Simply Wall St, the comprehensive app that offers global market insights for free. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include SHSE:600415 TPEX:6274 and TSE:6645. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
09-07-2025
- Business
- Yahoo
Asian Value Stocks: Damai Entertainment Holdings And 2 Companies That Could Be Priced Below Their Estimated Worth
As global markets experience varied performances, with the U.S. indices reaching record highs and mixed results in Europe and Asia, investors are increasingly attentive to opportunities within undervalued stocks across different regions. In this context, identifying stocks that may be priced below their estimated worth can offer potential value, particularly in Asian markets where economic indicators present a complex picture. Name Current Price Fair Value (Est) Discount (Est) Wanguo Gold Group (SEHK:3939) HK$30.25 HK$59.90 49.5% JRCLtd (TSE:6224) ¥1160.00 ¥2305.91 49.7% Jiangxi Rimag Group (SEHK:2522) HK$13.62 HK$27.23 50% Hibino (TSE:2469) ¥2365.00 ¥4709.96 49.8% Heartland Group Holdings (NZSE:HGH) NZ$0.82 NZ$1.63 49.5% Guangdong Marubi Biotechnology (SHSE:603983) CN¥42.35 CN¥84.40 49.8% Dive (TSE:151A) ¥935.00 ¥1857.63 49.7% Darbond Technology (SHSE:688035) CN¥39.53 CN¥78.42 49.6% cottaLTD (TSE:3359) ¥430.00 ¥855.22 49.7% Beijing Kawin Technology Share-Holding (SHSE:688687) CN¥26.51 CN¥52.74 49.7% Click here to see the full list of 277 stocks from our Undervalued Asian Stocks Based On Cash Flows screener. Below we spotlight a couple of our favorites from our exclusive screener. Overview: Damai Entertainment Holdings Limited is an investment holding company involved in content, technology, and IP merchandising and commercialization in Hong Kong and the People's Republic of China, with a market cap of HK$29.58 billion. Operations: The company's revenue is primarily derived from its Film Technology and Investment, Production, Promotion and Distribution Platform (CN¥2.71 billion), Damai (CN¥2.06 billion), IP Merchandising and Innovation Initiatives (CN¥1.43 billion), and Drama Series Production (CN¥499.92 million) segments. Estimated Discount To Fair Value: 31.1% Damai Entertainment Holdings, formerly Alibaba Pictures Group, is trading at HK$0.99, significantly below its estimated fair value of HK$1.44, highlighting its undervaluation based on cash flows. Despite recent insider selling and volatility in share price, the company reported increased sales of CNY 6.7 billion and net income growth to CNY 363.58 million for the fiscal year ending March 2025. Earnings are forecasted to grow substantially at over 40% annually, outpacing market averages in Hong Kong. The growth report we've compiled suggests that Damai Entertainment Holdings' future prospects could be on the up. Take a closer look at Damai Entertainment Holdings' balance sheet health here in our report. Overview: Guming Holdings Limited is an investment holding company that operates as a freshly made beverage company in the People's Republic of China, with a market cap of HK$67.30 billion. Operations: The company generates revenue from its non-alcoholic beverages segment, amounting to CN¥8.79 billion. Estimated Discount To Fair Value: 23.6% Guming Holdings is trading at HK$28.3, below its estimated fair value of HK$37.04, indicating substantial undervaluation based on cash flows. The company was recently added to the S&P Global BMI Index and forecasts suggest earnings will grow significantly at 20.8% annually, surpassing the Hong Kong market average of 10.4%. Despite high non-cash earnings, Guming's revenue growth rate of 17.8% per year remains slower than desired benchmarks but still exceeds market averages. Our expertly prepared growth report on Guming Holdings implies its future financial outlook may be stronger than recent results. Get an in-depth perspective on Guming Holdings' balance sheet by reading our health report here. Overview: Shenzhen Transsion Holdings Co., Ltd. manufactures and sells smart devices primarily in Africa and internationally, with a market cap of CN¥88.22 billion. Operations: Shenzhen Transsion Holdings Co., Ltd. generates revenue through the manufacturing and sale of smart devices across African markets and globally. Estimated Discount To Fair Value: 30.6% Shenzhen Transsion Holdings, trading at CN¥77.36, is currently valued below its fair value of CN¥111.43, highlighting significant undervaluation based on cash flows. Despite recent removal from the Shanghai Stock Exchange 180 Value Index and a decline in quarterly earnings to CN¥490.09 million from CN¥1,626.47 million year-on-year, revenue growth is forecasted at 13.2% annually, outpacing the Chinese market average of 12.4%. However, its dividend yield of 3.88% lacks adequate coverage by free cash flows. Insights from our recent growth report point to a promising forecast for Shenzhen Transsion Holdings' business outlook. Navigate through the intricacies of Shenzhen Transsion Holdings with our comprehensive financial health report here. Explore the 277 names from our Undervalued Asian Stocks Based On Cash Flows screener here. Got skin in the game with these stocks? Elevate how you manage them by using Simply Wall St's portfolio, where intuitive tools await to help optimize your investment outcomes. Unlock the power of informed investing with Simply Wall St, your free guide to navigating stock markets worldwide. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include SEHK:1060 SEHK:1364 and SHSE:688036. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Erreur lors de la récupération des données Connectez-vous pour accéder à votre portefeuille Erreur lors de la récupération des données Erreur lors de la récupération des données Erreur lors de la récupération des données Erreur lors de la récupération des données
